- Home
- / Hotgen
Hotgen
Stock Price
¥29.4
2024-10-29
Market Capitalization
¥2.7 B
2024-10-29
Revenue
¥389.6 M
FY, 2025
Hotgen Summary
Company Summary
- Overview
- Hotgen is a company that manufactures medical and public safety clinical products. It offers in vitro diagnostic reagents, an up-converting phosphor immunoassay analyzer, point of care testing, and biodefense instruments.
- Type
- Public
- Status
- Active
- Founded
- 2005
- HQ
- Beijing, CN | view all locations
- Website
- http://www.hotgen.com.cn
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Beijing, Bei Jing Shi HQ
China
No. 55 Qingfeng West Road
Hotgen Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥114.8M
- Gross profit (Q1, 2026)
- ¥59.7M
- Net income (Q1, 2026)
- (¥82.7M)
- Cash (Q1, 2026)
- ¥111.8M
- EBIT (Q1, 2026)
- (¥95.7M)
- Enterprise value
- $2.7B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026